Live Breaking News & Updates on Epigenic Therapeutics

Stay updated with breaking news from Epigenic therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Twice Rejected Diabetes Drug/Device Product Gets New Chance at Startup i2O

Intarcia Therapeutics’ GLP-1 agonist product candidate for type 2 diabetes now belongs to i2O Therapeutics, which will make the treatment’s case for approval at an upcoming FDA advisory committee meeting. The startup’s $46 million Series A financing is one of several recently announced funding rounds. ....

New Jersey , United States , San Diego , Harvard University , Samir Mitragotri , Andreesen Horowitz , Redmile Group , Rd Fund , Bain Capital Life Sciences , Intarcia Therapeutics , Sanofi Ventures , Epigenic Therapeutics , Qiming Venture Partners , Morningside Venture Capital , Superluminal Medicine , San Francisco Based Cellares , Koch Disruptive , Rapport Therapeutics , Asset Management , Genesis Therapeutics , Medcity News , Bain Capital Life , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News ,

Epigenic Therapeutics Announces $32 Million in Series A Funding to Bring Breakthrough Epigenome Medicine to Clinical Development

/PRNewswire/ Epigenic Therapeutics, a leading biotechnology company dedicated to developing next-generation gene modulation therapy utilizing epigenome. ....

United States , Hong Kong , Steven Wang , Kan Chen , Bob Zhang , Shanghai Stock Exchange , Shenzhen Stock Exchange , Qiming Venture Partners , Morningside Venture , Qiming Venture , Epigenic Therapeutics , Orbimed Asia , San Francisco Bay , Health Care Amp Hospitals , Medical Pharmaceuticals , Banking Amp Financial Services , Venture Capital , Financing Agreements ,

China Digest: Epigenic, Ronovo raise new capital; Trustar Capital to sell Moritex

Epigenic Therapeutics and Ronovo Surgical have raised new funding to advance their product R&D, while Trustar Capital is selling Moritex to Cognex Corp. ....

United States , Moritex Corporation , Moritex To Cognex Corporation , Trinity Innovation Fund , Cognex Corporation , Capital Holdings Ltd , Epigenic Therapeutics , Ronovo Surgical , Trustar Capital , Venture Partners , Qiming Venture , Morningside Venture Capital , Tigeryeah Capital , Kington Capital , Lilly Asia Ventures , Vivo Capital , Matrix Partners China , Longriver Investments , Holdings Ltd , Japan Based Moritex ,

Epigenic Therapeutics Raises $32M in Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time! ....

Bob Zhang , Epigenic Therapeutics , Qiming Venture Partners , Morningside Venture ,

Epigenic secures funds to advance gene editing therapy

Epigenic Therapeutics has secured $20m in Series Angel and Pre-A funding to proceed with next-generation gene editing therapy. ....

Michael Xue , Bob Zhang , Trinity Innovation Fund , Kingray Capital , Tigeryeah Capital , Morningside Venture Capital , Series Pre A , Fountainbridge Capital , Venture Capital , Epigenic Therapeutics ,